L Z. He, et.al., Two critical hits for promyelocytic leukemia., Molecular cell, 2000, 6

http://rdf.ncbi.nlm.nih.gov/pubmed/11106752

L Z. He, et.al., Two critical hits for promyelocytic leukemia., Molecular cell, 2000, 6

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(CTSG-RARA/ZBTB16)#Ppp
  http://metadb.riken.jp/db/mgi_rdf/MGI:3527936

class

http://purl.org/net/cito/citesAsAuthority

• Tg(CTSG-RARA/ZBTB16)#Ppp
  http://metadb.riken.jp/db/mgi_rdf/MGI:3527936

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• thrombocytopenia_Tg(CTSG-RARA/ZBTB16)#Ppp/0
  http://metadb.riken.jp/0003179NSTgCTSGRARAZBTB16Ppp0TgCTSGRARAZBTB16Ppp
• increased acute promyelocytic leukemia incidence_Tg(CTSG-ZBTB16/RARA)#Ppp/0,Zbtb16<tm1Ppp>/Zbtb16<tm1Ppp>
  http://metadb.riken.jp/0004049I129S1SvTgCTSGZBTB16RARAPpp0Zbtb16tm1PppZbtb16tm1PppTgCTSGZBTB16RARAPppZbtb16tm1Ppp
• decreased apoptosis_Tg(CTSG-RARA/ZBTB16)#Ppp/0
  http://metadb.riken.jp/0006043NSTgCTSGRARAZBTB16Ppp0TgCTSGRARAZBTB16Ppp
• myeloid hyperplasia_Tg(CTSG-RARA/ZBTB16)#Ppp/0
  http://metadb.riken.jp/0010373NSTgCTSGRARAZBTB16Ppp0TgCTSGRARAZBTB16Ppp
• abnormal bone marrow cell physiology_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0009278NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• enlarged spleen_Tg(CTSG-RARA/ZBTB16)#Ppp/0
  http://metadb.riken.jp/0000691NSTgCTSGRARAZBTB16Ppp0TgCTSGRARAZBTB16Ppp
• increased leukocyte cell number_Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0000218NSTgCTSGZBTB16RARAPpp0TgCTSGZBTB16RARAPpp
• abnormal myelopoiesis_Tg(CTSG-RARA/ZBTB16)#Ppp/0
  http://metadb.riken.jp/0001601NSTgCTSGRARAZBTB16Ppp0TgCTSGRARAZBTB16Ppp
• decreased apoptosis_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0006043NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• abnormal myelopoiesis_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0001601NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• increased acute promyelocytic leukemia incidence_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0004049NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• abnormal definitive hematopoiesis_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0002123NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• increased chronic myelocytic leukemia incidence_Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0005481NSTgCTSGZBTB16RARAPpp0TgCTSGZBTB16RARAPpp
• increased leukocyte cell number_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0000218NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• thrombocytopenia_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0003179NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• anemia_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0001577NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp
• increased leukemia incidence_Tg(CTSG-RARA/ZBTB16)#Ppp/0,Tg(CTSG-ZBTB16/RARA)#Ppp/0
  http://metadb.riken.jp/0002026NSTgCTSGRARAZBTB16Ppp0TgCTSGZBTB16RARAPpp0TgCTSGRARAZBTB16PppTgCTSGZBTB16RARAPpp